Artificial intelligence (AI)-enabled electrocardiogram (ECG) has proved to be a valuable screening tool for identifying individuals with reduced left ventricular ejection fraction (LVEF).
1 At Mayo Clinic, we have successfully developed and integrated an AI algorithm into our 12-lead ECG dashboard, facilitating early and non-invasive detection of reduced LVEF.
2–4 The objective of this report was to apply our recently developed AI-ECG algorithm in patients who underwent left bundle branch area pacing (LBBAP) to predict cardiac resynchronization therapy (CRT) outcomes in patients with heart failure and reduced ejection fraction (LVEF ≤ 50%).